BRIEF-Edwards Lifesciences Says FDA Grants De Novo Request For Acumen Hypotension Prediction Index Software​

* EDWARDS LIFESCIENCES CORP - ‍U.S. FDA GRANTED DE NOVO REQUEST FOR EDWARDS' ACUMEN HYPOTENSION PREDICTION INDEX SOFTWARE​ Source text for Eikon: Further company coverage:
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.